Asthma Clinical Trials in Aurora, Colorado

7 studies are recruiting for asthma in Aurora, Colorado right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

1. Registry of Asthma Characterization and Recruitment 3 (RACR3)

   This is a multi-center, non-interventional registry to create and maintain a database of participants to serve as a recruitment source for current and future DAIT NIAID-sponsored Childhood Asthma in Urban Settings (CAUSE) studies.

   Stage

   Not phased

   Ages

   Any age

   Site

   Children's Hospital Colorado: Allergy Program, Aurora, Colorado

   Locations

   7 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT05272241 on ClinicalTrials.gov

2. Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment

   The rationale of the roll-over study (ROSY) is to provide continuous access to study treatment for participants who have completed or exited a parent study and are deemed appropriate for continued benralizumab treatment, as judged by the Investigator, while monitoring long-term safety and tolerabil…

   Stage

   Phase 3

   Ages

   6 and older

   Site

   Research Site, Aurora, Colorado

   Locations

   45 in total

   Run by

   AstraZeneca

   See if you can join NCT07444567 on ClinicalTrials.gov

3. A Study of Efficacy and Safety of Depemokimab Compared With Placebo in Adults and Adolescents With at Risk Type 2 Asthma

   The aim of this study is to evaluate the efficacy of depemokimab administered as an adjunctive therapy, in participants with Type 2 asthma at risk of exacerbations compared to the guideline recommended standard of care (SoC).

   Stage

   Phase 3

   Ages

   12 and older

   Site

   GSK Investigational Site, Aurora, Colorado

   Locations

   17 in total

   Run by

   GlaxoSmithKline

   See if you can join NCT07456033 on ClinicalTrials.gov

4. Protocol CAUSE-03 / CHEETAH

   This is a one-year longitudinal, observational study of 250 urban children and adolescents with asthma and 60 without asthma, ages 6-17 years old. Participants with asthma will require daily controller therapy with inhaled corticosteroids ICS (at least Step 2 therapy). Those without asthma cannot h…

   Stage

   Not phased

   Ages

   6 to 17

   Site

   Children's Hospital Colorado: Allergy Program, Aurora, Colorado

   Locations

   8 in total

   Run by

   National Institute of Allergy and Infectious Diseases (NIAID)

   See if you can join NCT06136091 on ClinicalTrials.gov

5. Individualizing Treatment for Asthma in Primary Care (Full Study)

   While asthma therapy is becoming more individualized based on asthma phenotypes, more research is needed to tailor newer therapies to individuals. Inhaled corticosteroid (ICS) medications are the foundation of care for all individuals with persistent asthma. But ICS use is not without possible long…

   Stage

   Phase 4

   Ages

   13 to 75

   Site

   DARTNet Institute, Aurora, Colorado

   Locations

   13 in total

   Run by

   DARTNet Institute

   See if you can join NCT07052942 on ClinicalTrials.gov

6. Anti Inflammatory Lipid Mediators in Asthma Lipid Anti-Inflammtory Mediators in Asthma

   The main purpose of this Phase 2 double blind, placebo controlled crossover clinical study is to demonstrate the efficacy and safety of CXA-10 in obese adult asthmatics. Obesity induces a chronic systemic inflammatory state characterized by impaired adipokine signaling, pro-inflammatory cytokine re…

   Stage

   Phase 2

   Ages

   18 to 65

   Site

   University of Colorado Anschutz Medical Campus, Aurora, Colorado

   Run by

   University of Colorado, Denver

   See if you can join NCT03762395 on ClinicalTrials.gov

7. Obesity, Metabolic Dysregulation and the Airway Epithelium in Asthmatics

   The objective of this pilot study is to determine whether obesity and metabolic syndrome are in fact synergistic in relation to airway nitric oxide (NO) biology. To do so, the investigators want to determine how obesity and the metabolic syndrome relate to metabolism in bronchial airway epithelial …

   Stage

   Not phased

   Ages

   18 to 65

   Site

   University of Colorado, Aurora, Colorado

   Run by

   University of Colorado, Denver

   See if you can join NCT03215836 on ClinicalTrials.gov